Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Clinical & Experimental Metastasis|April 10, 2012
VEGFR-1 expression levels predict occurrence of disseminated tumor cells in the bone marrow of patients with esophageal carcinomaAlexander Schultze, Isabel Ben Batalla, Sabine Riethdorf, et al.
Cell Reports|July 15, 2014
Bromodomain protein BRD4 is required for estrogen receptor-dependent enhancer activation and gene transcriptionSankari Nagarajan, Tareq Hossan, Malik Alawi, et al.
Oncotarget|April 8, 2015
Cyclooxygenase-2 blockade can improve efficacy of VEGF-targeting drugsIsabel Ben-Batalla, Miguel Cubas-Cordova, Florian Udonta, et al.
Life Science Alliance|May 16, 2022
The HDL particle composition determines its antitumor activity in pancreatic cancerRaimund Oberle, Kristina Kührer, Tamina Österreicher, et al.
Haematologica|March 24, 2018
BET-inhibition by JQ1 promotes proliferation and self-renewal capacity of hematopoietic stem cellsMark Wroblewski, Marina Scheller-Wendorff, Florian Udonta, et al.
Hemasphere|August 16, 2021
AXL Inhibition Represents a Novel Therapeutic Approach in <i>BCR-ABL</i> Negative Myeloproliferative NeoplasmsAntonia Beitzen-Heineke, Nikolaus Berenbrok, Jonas Waizenegger, et al.
Cancer Research|December 30, 2016
Cetuximab Resistance in Head and Neck Cancer Is Mediated by EGFR-K<sub>521</sub> PolymorphismFriederike Braig, Malte Kriegs, Minna Voigtlaender, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2016
Axl Blockade by BGB324 Inhibits BCR-ABL Tyrosine Kinase Inhibitor-Sensitive and -Resistant Chronic Myeloid LeukemiaIsabel Ben-Batalla, Robert Erdmann, Heather Jørgensen, et al.
Nature Communications|December 12, 2022
Regulation of bone homeostasis by MERTK and TYRO3Janik Engelmann, Jennifer Zarrer, Victoria Gensch, et al.
Pageof 3